InterMune completes sale of Actimmune
04:45 EDT 21 Jun 2012 | Pharmaceutical Business Review
InterMune has completed divestiture of Actimmune (interferon gamma-1b) to Vidara Therapeutics, a part of an international specialty pharmaceutical group of companies with operations in Ireland and the US.
Original Article: InterMune completes sale of Actimmune
More From BioPortfolio on "InterMune completes sale of Actimmune"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
